Babcock & Wilcox director exercises and receives RSUs
Babcock & Wilcox Enterprises director Dr. Homaira Akbari reported equity-based compensation activity.
Rhea-AI Filing Summary
Babcock & Wilcox Enterprises director Dr. Homaira Akbari reported equity-based compensation activity. On May 15, 2026, she exercised 3,021 shares of common stock at $21.22 per share from restricted stock units and held 53,021 common shares afterward.
She also received 8,725 new restricted stock units tied to common stock, which vest on May 15, 2027 or the next annual meeting, and previously received 3,021 restricted stock units that vest on May 15, 2026. After these grants, she directly holds both common shares and unvested restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,021 shares exercised/converted
Exercise
4 txns
Insider
Akbari Dr. Homaira
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,021 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 8,725 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,021 | $21.22 | $64K |
| Grant/Award | Restricted Stock Units | 3,021 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 8,725 contracts (Direct);
Common Stock — 53,021 shares (Direct)
Footnotes (3)
- F1. Vests May 15, 2026 or date of next Annual Meeting, whichever is earlier.
- F2. Pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated 2021 Long-Term Incentive Plan and represents a contingent right to receive one share of common stock.
- F3. Vests May 15, 2027 or date of next Annual Meeting, whichever is earlier.
Key Figures
RSUs exercised into common: 3,021 shares at $21.22
Common shares held after exercise: 53,021 shares
New RSU grant (2026): 8,725 restricted stock units
+2 more
5 metrics
RSUs exercised into common
3,021 shares at $21.22
Exercise of derivative security on May 15, 2026
Common shares held after exercise
53,021 shares
Direct ownership following May 15, 2026 transaction
New RSU grant (2026)
8,725 restricted stock units
Grant on May 15, 2026 under long-term incentive plan
Prior RSU grant (2026 vesting)
3,021 restricted stock units
Grant dated January 29, 2026
Underlying common for new RSUs
8,725 shares
Each RSU represents one BW common share
Key Terms
Restricted Stock Units, Exercise or conversion of derivative security, Grant, award, or other acquisition, Amended and Restated 2021 Long-Term Incentive Plan
4 terms
Restricted Stock Units financial
"security_title: Restricted Stock Units; represents a contingent right to receive common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Amended and Restated 2021 Long-Term Incentive Plan financial
"Pursuant to Babcock & Wilcox Enterprises, Inc. Amended and Restated 2021 Long-Term Incentive Plan"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did BW director Dr. Homaira Akbari report?
Dr. Homaira Akbari reported equity awards and an option-style exercise. She exercised 3,021 restricted stock units into common stock at $21.22 per share and received additional restricted stock units as compensation, reflecting routine long-term incentive activity rather than open-market buying or selling.
What new restricted stock units did Dr. Akbari receive from BW?
Dr. Akbari received 8,725 new restricted stock units on May 15, 2026. These units represent a contingent right to receive an equal number of BW common shares and were granted under the company’s Amended and Restated 2021 Long-Term Incentive Plan.
When do Dr. Akbari’s BW restricted stock units vest?
The filing discloses two vesting schedules for her restricted stock units. One grant vests on May 15, 2026, or the next annual meeting, whichever is earlier, and another vests on May 15, 2027, or the date of the next annual meeting, whichever occurs first.
Were Dr. Akbari’s BW transactions open-market purchases or sales?
The reported BW transactions are not open-market trades. They consist of grants of restricted stock units and the exercise or conversion of previously awarded units, all recorded as acquisitions, rather than discretionary buying or selling of shares in the open market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
